Patients (pts) with brain metastases (BM) had clinically meaningful lower health-related quality of life (HRQoL) on the emotional well-being subscale than the general population prior to stereotactic radiosurgery (SRS); pre-SRS HRQoL state should be measured in order to accurately interpret changes in HRQoL over time following treatment.
Why this matters
In pts with BM, HRQoL is one of the most important factors in choosing from different treatment options.
Clinicians and nursing staff should be informed on the pre-SRS HRQoL state of pts with BM to better understand their specific needs on the day of treatment.
Differing results on different HRQoL subscales in this study highlight the need for further studies assessing all aspects of HRQoL separately.